Contents
Academic literature on the topic 'Dépression – Tests – Évaluation'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dépression – Tests – Évaluation.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Dépression – Tests – Évaluation"
Guelfi, J. D. "Critères diagnostiques, échelles et questionnaires utilisés au cours des dépressions." Psychiatry and Psychobiology 3, S1 (1988): 63s—70s. http://dx.doi.org/10.1017/s0767399x00002662.
Full textIcick, R., E. Karsinti, V. Bloch, J. P. Lépine, J. L. Laplanche, F. Bellivier, and F. Vorspan. "Associations différentielles de différents dysfonctionnements parentaux avec un début plus précoce d’usage de substances chez des patients stabilisés sous méthadone." European Psychiatry 30, S2 (November 2015): S104—S105. http://dx.doi.org/10.1016/j.eurpsy.2015.09.196.
Full textLehnung, Maria, Elan Shapiro, Melanie Schreiber, and Arne Hofmann. "Évaluation du protocole EMDR de traitement en groupe d’épisodes traumatiques avec des réfugiés : une étude de terrain." Journal of EMDR Practice and Research 12, no. 4 (November 2018): E77—E86. http://dx.doi.org/10.1891/1933-3196.12.4.e77.
Full textDembri, Aïcha N., and Jocelyn Aubut. "A Comparative Study of Elective Abortion and Childbirth among Young Women in Quebec." Rorschachiana 24, no. 1 (January 2000): 88–109. http://dx.doi.org/10.1027/1192-5604.24.1.88.
Full textDissertations / Theses on the topic "Dépression – Tests – Évaluation"
Orendain, Mónica. "Les relations d'objet, la dualité anaclitique-introjective et leur relation avec les symptômes dépressifs." Doctoral thesis, Université Laval, 2010. http://hdl.handle.net/20.500.11794/21962.
Full textCléry-Melin, Galichon Marie-Laure. "Étude des fonctions neurocognitives dans la dépression : caractérisation de déficits motivationnels et cognitifs, évaluation de leur valeur pronostique Why don't you try harder? An investigation of effort production in major depression Neural mechanisms underlying motivation of mental versus physical effort Psychomotor retardation is a scar of past depressive episodes, revealed by simple cognitive tests Are cognitive deficits in major depressive disorder progressive? A simple attention test in the acute phase of a major depressive episode is predictive of later functional remission Progress in elucidating biomarkers of antidepressant pharmacological treatment response: a systematic review and meta-analysis of the last 15 years Stability of the diagnosis of seasonal affective disorder in a long-term prospective study." Thesis, Sorbonne Paris Cité, 2018. http://www.theses.fr/2018USPCB218.
Full textHese deficits coexist in the acute phase of a depressive episode and interfere with decision-making and goal-directed behaviors, and the associated feeling of effort. They appear to persist in periods of clinical remission, decreasing the quality of the therapeutic and functional response and lately worsening the prognosis of the disorder. The aim of this work is to identify objectively measurable neurocognitive markers in clinical practice, and to study their association with the prognosis of a depressive episode, in order to better predict remission and potentially to optimize therapeutic prescribing strategies for patients accordingly. The impairment of neurocognitive processes related to reward constitutes a first vulnerability marker for major depressive disorder (MDD): in a study assessing the production of motor effort in order to obtain a reward, depressed patients had a deficit in production of effort, unlike healthy subjects. Such deficit in incentive motivation - a process underpinned by the activation of ventral cortico-striatal circuits in healthy subjects - may constitute a specific dimension of MDD. It participates in the decision-making and action processes impairments and is associated with – and possibly a consequence of- more specifically cognitive deficits. In a study assessing several cognitive functions in a large cohort of depressed patients, the persistence of psychomotor retardation after 6 to 8 weeks of treatment - in patients considered as being in clinical remission - was positively and independently correlated with the number of past depressive episodes, thus constituting a marker of "cumulative" marker of past depressive episodes. Finally, in a literature review on the progressive evolution of cognitive deficits in MDD, we discussed the existence of a “neurotoxic” effect of the lifetime accumulation of depressive episodes on neurocognitive deficits and its consequences on disease prognosis (increased risk of incomplete functional/clinical remission, relapses, evolution towards dementia). One of the main interest in identifying clinical and cognitive markers of vulnerability is to highlight their capacity to predict the course of a depressive episode-or disorder. In a study based on a cohort of more than 500 depressed patients, a measurement of attention (d2 attention test) was able to significantly and independently predict the subsequent course towards complete remission (clinical and functional) and to constitute a trait -marker of depression, easy to use in clinical practice. Other cognitive markers (such as executive functions) have shown high predictive values for therapeutic response, comparable to those provided by imaging or electrophysiology markers, according to the results of a recent meta-analysis, that emphasizes the interest of using them in patient’s follow-up. Finally, in order to better assess the prognosis of depressive disorder, we have shown that Seasonal Affective Disorder (SAD) diagnosis criteria - which nevertheless represents a specific depressive disorder with well-known physiopathology substrates (construction validity) - had a low predictive validity, prompting to consider this disorder as a temporary expression of a mood disorder, rather than a specific disorder. The identification of clinical tools measuring motivational and cognitive deficits in clinical routine and predicting the course of a depressive episode or disorder represents a major challenge in the improvement of personalized therapeutic management and the long-term prognosis in depressed patients
Gaudout-Poudens, Laure. "Evaluation gérontologique standardisée : expérience en médecine générale avec réalisation d'une enquête prospective." Bordeaux 2, 2000. http://www.theses.fr/2000BOR2M087.
Full textDelpech, Lionel. "Dépression et musicothérapie : une construction d'outil, une évaluation de dispositif et une créativité en action." Thesis, Toulouse 2, 2019. http://www.theses.fr/2019TOU20056.
Full textThe Receptive Projective Composite Montage (RPCM) is a short-term psychotherapy which includes a musical medium. The RPCM combines a musical induction technique with a clinical interview in order to help in-patients during the treatment of their depression. This thesis contains three studies which aim at showing the therapeutic efficiency of the RPCM against depression and to explore, confirm and allow the confirmation of the therapeutic processes at stake. The first study is a research project on one of the RPCM components, that is the RCM. It is a musical induction technique that causes a positive state and a relaxation state to in-patients who receive psychiatric treatment for depression. Based on 37 subjects, the results confirm the anticipated effects of the technique. This tool improves the in-patient's comfort and can be used with other psychotherapies to strengthen the therapeutic alliance. The second study evaluates the efficiency of the RPCM on the depression level of in-patients diagnosed with depression. Moreover, a qualitative analysis has been performed in order to identify the therapeutic processes reported from the patients themselves. The results show that in patients who received the RPCM over three sessions have a lower depression level as opposed to other in-patients. The identified processes are: emotional, cognitive, conative and clinical. The most relevant phenomenon is imagination. The third and last study allowed to psychometrically validate a creativity test: the Epstein Creativity Competencies Inventory for Individuals (French version: ECCI-i-FR). Gathered from 280 individuals contacted through the internet, results show that the tool has a nomological and concurrent validity as well as a satisfactory accuracy. These results allow for the usage of the ECCI-i-FR in numerous fields, especially in psychiatric research or for the evaluation of mediatized therapies, such as the RPCM